Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England newborn screening program

Clinical Chemistry

Volumn 47, Issue 11, 2001, Pages 1945-1955

  Zytkovicz, T H ^a   Fitzgerald, E F ^a   Marsden, D ^a   Larson, C A ^a   Shih, V E ^a   Johnson, D M ^a   Strauss, A W ^a   Comeau, A M ^a   Eaton, R B ^a   Grady, G F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; AMINO ACID; ARGININE; ARGININOSUCCINATE LYASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; METHIONINE; METHYLCROTONOYL COENZYME A CARBOXYLASE; PHENYLALANINE; PROPIONIC ACID;

AMINO ACID METABOLISM; ARTICLE; BLOOD STAIN; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DISORDERS OF CARBOXYLIC ACID METABOLISM; ENZYME DEFICIENCY; FATTY ACID METABOLISM; HUMAN; HYPERPHENYLALANINEMIA; MAJOR CLINICAL STUDY; MAPLE SYRUP URINE DISEASE; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA; PROPIONIC ACIDEMIA; TANDEM MASS SPECTROMETRY;

ACER;

EID: 0034775820     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.11.1945     Document Type: Article

References (34)

1. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry
2. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry
3. Rapid diagnosis of homocystinuria and other hypermethionemias from newborns' blood spots by tandem mass spectrometry
4. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 h
5. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue
6. Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
7. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects
8. Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias
9. 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: A new inborn error of L-leucine metabolism
10. Rapid diagnosis of MCAD deficiency: Quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry
11. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Diagnosis by acylcarnitine analysis in blood
12. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microbatch process and a computer algorithm for automated flagging of abnormal profiles
13. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry
14. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia
15. Mutations in medium chain acyl-CoA dehydrogenase (MCAD) gene
16. Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point mutation (A985) in the MCAD gene
17. Isolated isobutyryl-CoA dehydrogenase deficiency: An unrecognized defect in human valine metabolism
18. Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded screening with tandem mass spectrometry
19. Tandem mass spectrometry newborn screening: Differences between full term and premature neonates
20. Transient tyrosinemia in full-term infants
21. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxylacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders
22. The molecular basis of medium-chain acyl-coenzyme A dehydrogenase deficiency: An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation
23. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: One of the variant alleles, 511C→T, is present at an unexpectedly high frequency in the general population, as was the case for 625G→A, together conferring susceptibility to ethylmalonic aciduria
24. Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency
25. Acyl-CoA dehydrogenase deficiencies
26. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies
27. Molecular lesions in patients with medium-chain acyl-CoA dehydrogenase deficiency
28. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency
29. Medium-chain acylcoenzyme A deficiency and sudden infant death
30. Workshop on molecular aspects of MCAD deficiency. Mutations causing medium-chain acyl-CoA dehydrogenase deficiency. A collaborative compilation of the data from 172 patients
31. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency
32. The magnitude and challenge of false-positive newborn screening results
33. Tandem mass spectrometry screening: Proving effectiveness